FDA approves Roche’s kidney inflammation drug
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomised phase III study
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomised phase III study
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Brenntag Specialties will provide pharmaceutical manufacturers and biopharmaceutical companies with a reliable supply of high-purity, GMP-compliant acetates
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
The complex four-hour surgery was performed by a multidisciplinary team of doctors
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
Subscribe To Our Newsletter & Stay Updated